James F. Farrington, Jr.

Partner

James F. Farrington, Jr.
Partner
office Stamford
phone 203-363-7614
fax203-363-7676
emailjfarrington@wiggin.com
view LinkedIn profile


Biography

Jim is a career-long life sciences attorney who has spent decades focusing on transactions for life sciences companies, often in Europe.

A longtime Partner in the firm's Corporate Department and Life Sciences Practice Group, he is dedicated to helping life science companies address unmet needs to improve human health. His diverse background, including science and engineering, helps him address the intersection of science, medicine, business, and the law.

Jim's practice includes commercial business transactions, especially acquisitions; joint ventures; licensing and other technology transfer transactions; and research, manufacturing, and marketing agreements, often for clients in Scandinavia. He also teaches at the Notre Dame Law School.

Jim was inducted into the LMG Life Sciences Hall of Fame in 2017, an honor for veteran life science attorneys who have built exceptional careers. It capped decades of honors, including "highly recommended status in corporate partnering by Practical Law Company/Global Counsel, a "Leader in their Field" designation in Sweden in Chambers Europe, a listing in The Best Lawyers in America for biotechnology law, and recognition as a "Life Science Star" for mergers and acquisitions and for licensing and collaboration in LMG Life Sciences.

Jim and his family lived in Stockholm for two years while he was leading the legal team for a global business transaction.

Jim received his law degree with high honors from Quinnipiac University School of Law and a B.Ch.E. from the University of Notre Dame.

After obtaining his Bachelor's, Jim worked as an engineering and product manager for nearly nine years in the air pollution control field. Before joining Wiggin and Dana, Jim was a partner in the New York office of Mannheimer Swartling, Sweden's largest law firm.

News

09.22.2017Six Wiggin and Dana Partners Recognized as New York Best Lawyers 2018
09.14.2017Wiggin and Dana Partner Inducted Into the LMG Hall of Fame
08.15.2017Best Lawyers in America Recognizes 30 Lawyers from Wiggin and Dana
07.17.2017Wiggin and Dana Partners Recognized By LMG Life Sciences
10.26.2016Wiggin and Dana Partners Recognized By LMG Life Sciences
08.15.2016Best Lawyers in America Recognizes 30 Lawyers from Wiggin and Dana
07.12.2016Wiggin and Dana Advises Cormorant Pharmaceuticals AB in sale to Bristol-Myers Squibb
09.18.2015Wiggin and Dana Partners Recognized By LMG Life Sciences
08.27.2015Wiggin and Dana Advises Alligator Bioscience AB in Licensing Agreement with Janssen Biotech, Inc.
08.17.2015Best Lawyers in America Recognizes 31 Lawyers from Wiggin and Dana
04.14.2015Wiggin and Dana Ranked in BioPharm Insight's Licensing League Tables
11.18.2014Wiggin and Dana Advises Galecto Biotech AB in Option for Bristol-Myers to Acquire Galecto
08.19.2014Best Lawyers in America Recognizes 33 Lawyers from Wiggin and Dana
08.15.2013Best Lawyers in America Recognizes 35 Lawyers from Wiggin and Dana
08.07.2013Wiggin and Dana Partners Recognized By LMG Life Sciences
07.22.2013Wiggin and Dana Partners Named to Who's Who Legal
07.12.2012Wiggin and Dana Lawyers Recognized by LMG Life Sciences
09.13.2011Best Lawyers in America Recognizes 32 Lawyers from Wiggin and Dana
11.08.2010Wiggin and Dana Lawyers Named to Who's Who Legal
08.02.2007Wiggin and Dana Counsel to Meda as it Enters U.S. Market with MedPointe Acquisition
12.05.2006Wiggin and Dana's Life Sciences Group Named Among Top 10 in U.S. by PLC Which Lawyer?
11.10.2006Wiggin and Dana Represents Meda AB in 3M's $2.1 billion Divestment of 3M's Pharmaceutical Business
08.31.2004Wiggin and Dana ranked Highly Recommended by Global Counsel for Corporate Partnering in Life Sciences
05.27.2004James Farrington quoted in The Daily Deal on biotech funding
06.30.2003Farrington Presents at BIO2003 on Big Pharma Spin-Offs that Work
03.30.2003Wiggin & Dana ranked Highly Recommended in Global Counsel for Corporate Partnering in Life Sciences
03.17.2003Swedish Biotech firms ask for American Assistance
12.03.2002Wariness, Hope Pervaded $150M Deal
10.23.2002Wiggin & Dana Closes $150 Million Deal for One of Largest Biotech Companies in Europe
02.28.2002Technology, and the Legal Expertise to Handle Growing Companies
05.10.2000Karo Bio's acquision of the American biotechnology company Novalon Pharmaceutical Corporation was completed today along the lines announced in Karo Bio's March 27 press release

office Stamford
phone 203-363-7614
fax203-363-7676
emailjfarrington@wiggin.com
view LinkedIn profile

PRACTICE GROUPS

EDUCATION

  • Quinnipiac University School of Law, J.D., 1984, magna cum laude
  • University of Notre Dame, B.Ch.E, 1974

BAR ADMISSIONS

  • Connecticut
  • New York


CONNECTICUT   |   NEW YORK   |   PHILADELPHIA   |   WASHINGTON, DC   |   PALM BEACH
© 1998-2018 Wiggin and Dana LLP   |   Disclaimer Notice   |   Attorney Advertisement   |   Privacy Policy   |   Contact
wiggin.com
© 1998-2018 Wiggin and Dana LLP